Other

Interest Income (Expense), Operating

Zimmer Biomet Holdings Interest Income (Expense), Operating increased by 4.3% to -$68.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.9%, from -$66.20M to -$68.80M. Over 4 years (FY 2021 to FY 2025), Interest Income (Expense), Operating shows a downward trend with a 8.9% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026

How to read this metric

A net expense indicates debt-heavy financing, while net income suggests a strong cash position or high-yield investments.

Detailed definition

Net interest income or expense represents the difference between interest earned on cash and investments and interest pa...

Peer comparison

Depends on the capital structure; defense companies typically maintain moderate leverage to fund long-term projects.

Metric ID: other_interest_income_expense_net

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$54.70M-$52.60M-$48.80M-$41.10M-$38.80M-$42.30M-$42.60M-$48.20M-$51.60M-$51.10M-$50.30M-$50.70M-$51.10M-$54.30M-$61.90M-$66.20M-$79.30M-$75.40M-$71.90M-$68.80M
QoQ Change+3.8%+7.2%+15.8%+5.6%-9.0%-0.7%-13.1%-7.1%+1.0%+1.6%-0.8%-0.8%-6.3%-14.0%-6.9%-19.8%+4.9%+4.6%+4.3%
YoY Change+29.1%+19.6%+12.7%-17.3%-33.0%-20.8%-18.1%-5.2%+1.0%-6.3%-23.1%-30.6%-55.2%-38.9%-16.2%-3.9%
Range-$79.30M-$38.80M
CAGR+4.9%
Avg YoY Growth-12.9%
Median YoY Growth-16.7%
Current Streak3 quarters growth

Interest Income (Expense), Operating at Other Companies

Frequently Asked Questions

What is Zimmer Biomet Holdings's interest income (expense), operating?
Zimmer Biomet Holdings (ZBH) reported interest income (expense), operating of -$68.80M in Q1 2026.
How has Zimmer Biomet Holdings's interest income (expense), operating changed year-over-year?
Zimmer Biomet Holdings's interest income (expense), operating decreased by 3.9% year-over-year, from -$66.20M to -$68.80M.
What is the long-term trend for Zimmer Biomet Holdings's interest income (expense), operating?
Over 4 years (2021 to 2025), Zimmer Biomet Holdings's interest income (expense), operating has grown at a 8.9% compound annual growth rate (CAGR), from -$208.40M to -$292.80M.
What does interest income (expense), operating mean?
The net cost or gain from interest-bearing assets and liabilities.